Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by WatchLearnEarnon Mar 14, 2018 9:53pm
324 Views
Post# 27717616

Antibe already bought me a 3-unit investment property

Antibe already bought me a 3-unit investment propertyGotta love those "No Material Change" announcements. Today's consolidation hiccup aside, Antibe is still very much on the upswing in anticipation of news next week. That's why I hated selling some (avg $0.41!) but I still have lots of shares in another account and had to make sure there was enough time for T+2 and to wire the funds to my bank by next Monday for the closing.

My new rental property is a bit of a fixer (all the good deals are!) but should have great cash flow once renovated. The stock market is exciting and it's a wild ride when you finally hit, but it's time for me to diversify with some good old, conservative real estate.

Can't wait to see where this goes once ATB-346 topline results are released!

Good luck everyone.

Bullboard Posts